Last reviewed · How we verify
NCT05541042
Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers
trial testing Observational only in Glioblastoma in 50 participants. Not yet recruiting.
1 November 2025
Quick facts
| Lead sponsor | Henan Provincial People's Hospital |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 1 December 2022 |
| Primary completion | 1 November 2025 |
| Estimated completion | 1 November 2027 |
| Sites | 1 location across China |
Drugs / interventions tested
- Observational only
Conditions studied
- Glioblastoma — all drugs for Glioblastoma →
Sponsor
Henan Provincial People's Hospital
Who can join
18 and older, any sex, with Glioblastoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate relationships between multiparametric imaging biomarkers and genetic analysis in glioblastoma patients.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.
Seyhan AA. · · 2024 · cited 44× · PMID 39063215 · DOI 10.3390/ijms25147974 -
Application of Circulating Tumor DNA in the Auxiliary Diagnosis and Prognosis Prediction of Glioma.
Lu Y, Wang Z, Zhang D, Luo N, et al · · 2024 · cited 7× · PMID 39692767 · DOI 10.1007/s10571-024-01515-z
Verify or expand the search:
- PubMed search for NCT05541042
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Observational only
Trials testing the same drug.
- NCT06107933 — Developmental Impacts of Microplastics Exposure in Early Life · recruiting
- NCT05730387 — Smart Discharges for Mom & Baby · completed
- NCT04361591 — COVID-19 in Liver Transplant Recipients · completed
- NCT05022979 — Prevalence and Risk Factors for Micronutrient Deficiencies During Pregnancy in Cayenne, French Guiana · completed
- NCT03583957 — A Wireless EEG Patch for Continuous Electrographic Monitoring · NA · enrolling by invitation
Other recruiting trials for Glioblastoma
Currently open trials in the same condition.
- NCT07284069 — Senicapoc and Perampanel for Newly Diagnosed Glioblastoma · EARLY_PHASE1 · recruiting
- NCT05653635 — Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study · Phase 2 · recruiting
- NCT07480941 — Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma · Phase 1 · recruiting
- NCT07448480 — Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant Gliomas · active not recruiting
- NCT07410676 — EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors · Phase 1, PHASE2 · recruiting
Other Henan Provincial People's Hospital trials
Trials by the same sponsor.
- NCT07250230 — Effect of Perioperative High-dose Transdermal Nicotine Patch on Pain Sensitivity Among Male Abstinent Tobacco Smokers Un · NA · recruiting
- NCT07268872 — Dynamic Effects of Different Anesthetic Agents on the Immune Function of Healthy Volunteers · NA · enrolling by invitation
- NCT07390929 — Clinical Trial Study on the Improved New Method of Acupotomy for AS · NA · recruiting
- NCT07033871 — Comprehensive Geriatric Assessment in Chronic Disease Management for Older Adults in China: A Registry Study （CGACDM - O · not yet recruiting
- NCT06929390 — Comparing BTVA and MWA in COPD With Early Lung Cancer: Efficacy and Safety · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05541042 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Henan Provincial People's Hospital
- Last refreshed: 27 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05541042.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing